TI
TTPH

Turner Investments’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Turner Investments’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-104
Closed -$76K – 423
2015
Q1 		$76K Sell
104
-48
-32% -$36.1K 0.01% 322
2014
Q4 		$120K Sell
152
-135
-47% -$72.7K 0.01% 450
2014
Q3 		$114K Hold
287
– – 0.01% 498
2014
Q2 		$77K Buy
+287
New +$61.6K ﹤0.01% 521

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Turner Investments's TTPH Position: Q2 2015 in Review

Turner Investments sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2015, closing a stake of 104 shares — an estimated $76K sold.

Turner Investments first reported a position in TTPH in Q2 2014 and held it in 4 quarters. The position peaked at $120K in Q4 2014. 139 funds tracked by Wall St. Rank hold TTPH as of Q2 2015.

  • Turner Investments reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Turner Investments sold 104 Tetraphase Pharmaceuticals, Inc. shares in Q2 2015, an estimated $76K.
  • Turner Investments first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2014 and held it in 4 quarters.
  • Turner Investments's Tetraphase Pharmaceuticals, Inc. position peaked at $120K in Q4 2014.
  • 139 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2015.

Based on Turner Investments's 13F filing for Q2 2015, filed 12 Aug 2015.